30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

DJO Global 3Q16 Revenue -

DJO Global posted 3Q16 revenue of US $287.2MM, +3.2% vs. 3Q15. Growth is as-reported.

ORTHOWORLD estimates 3Q16 segment sales and growth on an as-reported basis as follows:

  • Joint Reconstruction $50.2MM, +12.6%
    • Hips $11.7MM, +4.9%
    • Knees $13.5MM, +21.2%
    • Extremities $25.0MM, +12.2%
  • Other $237.0MM, +1.4% (Includes Bracing/Vascular, Recovery Sciences and also International revenue not already attributed to Joint Recon)


  • Strong performance in Surgical Implants: shoulder, hip and knee growing far ahead of the market
  • Growth driven by major product launches, including the Altivate shoulder, EMPOWR 3D and EMPOWR PS knees
  • Anniversaried the acquisition of bone cement and elbow from Biomet
  • Organically, excluding bone cement and elbow, Surgical Implant sales grew +28% driven by continued strength in core product lines, with growth rates at 23% in shoulders, 69% knees, 23% hips

Sources: DJO Global, Inc.; ORTHOWORLD Inc.



This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.